Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy
Abstract Background Since December 2019, the COVID-19 pandemic has changed the concept of medicine. This work aims to analyze the use of antibiotics in patients admitted to the hospital due to SARS-CoV-2 infection. Methods This work analyzes the use and effectiveness of antibiotics in hospitalized p...
Guardado en:
Autores principales: | Alejandro David Bendala Estrada, Jorge Calderón Parra, Eduardo Fernández Carracedo, Antonio Muiño Míguez, Antonio Ramos Martínez, Elena Muñez Rubio, Manuel Rubio-Rivas, Paloma Agudo, Francisco Arnalich Fernández, Vicente Estrada Perez, María Luisa Taboada Martínez, Anxela Crestelo Vieitez, Paula Maria Pesqueira Fontan, Marta Bustamante, Santiago J. Freire, Isabel Oriol-Bermúdez, Arturo Artero, Julián Olalla Sierra, María Areses Manrique, H. Francisco Javier Carrasco-Sánchez, Vanessa Carolina Vento, Gema María García García, Pablo Cubero-Morais, José-Manuel Casas-Rojo, Jesús Millán Núñez-Cortés |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a934fba04e7b4410bb5505c10cacb408 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mechanisms of Resistance to Macrolide Antibiotics among <i>Staphylococcus aureus</i>
por: Maria Miklasińska-Majdanik
Publicado: (2021) -
Sub-Inhibitory Antibiotic Exposure and Virulence in <i>Pseudomonas aeruginosa</i>
por: Charlotte Nolan, et al.
Publicado: (2021) -
Problemas de resistencia en Streptococcus pyogenes
por: Camponovo C.,Rossanna
Publicado: (2002) -
Terapia triple de corto tiempo con azitromicina, amoxicilina y omeprazo para la erradicación del Helicobacter pylori
por: Flores O,Sergio, et al.
Publicado: (2000) -
A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin–0.1% dexamethasone combination compared to 1% azithromycin alone, dexamethasone 0.1% alone, and vehicle in the treatment of subjects with blepharitis
por: Hosseini K, et al.
Publicado: (2016)